| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | Oncomine Dx Express Test |
| Generic Name | Next generation sequencing oncology panel, somatic or germline variant detection system |
| Applicant | Life Technologies Corporation 7335 Executive Way Frederick, MD 21704 |
| PMA Number | P240040 |
| Supplement Number | S008 |
| Date Received | 08/21/2026 |
| Decision Date | 11/04/2026 |
| Product Code |
PQP |
| Advisory Committee |
Pathology |
| Supplement Type | Real-Time Process |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for Genexus Dx Software Security Patch version 6.8.2.2 to address the vulnerabilities discovered on the Genexus Dx Software. |
|
|